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Certain pathotypes of Escherichia coli are important causes of diarrhoea in children, especially in the developing countries of sub-Saharan Africa and South Asia1. Intestinal E. coli is 
also an important source and reservoir of genes that encode antimi-
crobial resistance (AMR). One pathotype of intestinal E. coli, known 
as atypical enteropathogenic E. coli (aEPEC), is defined by the pres-
ence of the locus of enterocyte effacement pathogenicity island, 
and the absence of Shiga toxins (denoting enterohaemorrhagic 
E. coli) and type IV bundle-forming pili (indicating typical EPEC)2. 
Atypical enteropathogenic E. coli causes a variety of disease symp-
toms ranging from sporadic and persistent diarrhoea to asymptom-
atic carriage1,3–5. We recently identified distinct lineages of aEPEC, 
including ten common clonal groups6.
AMR has been reported in E. coli from various animal species, 
the environment and in hospitalized patients globally7–12. Many 
strains exhibit multi-drug resistance (MDR; resistance to one or 
more agents in at least three different antimicrobial categories13). 
Strains that are resistant to fluoroquinolones and/or produce 
extended-spectrum β -lactamases (ESBL) or carbapenemases are of 
particular concern14. Although several recent studies of pathogenic 
E. coli from countries in sub-Saharan Africa and South Asia have 
reported increases in ESBLs15,16, as well as increasing resistance to 
gentamicin17,18 and ciprofloxacin18–22, these data are mostly derived 
from E. coli responsible for extra-intestinal infections in hospital 
settings. Thus, there remain major gaps in knowledge of the global 
prevalence of AMR in human intestinal E. coli, particularly in devel-
oping nations where the burden of infectious diseases is highest and 
AMR may result in infections that are unresponsive to treatment14.
Enhancing our knowledge of AMR amongst gut-dwelling 
E. coli is important for two reasons: (1) E. coli is a leading cause of 
extra-intestinal infections and strains colonising the gastrointestinal 
tract of patients are the major reservoir of these infections; and 
(2) most AMR in E. coli is encoded on mobile genetic elements that 
are transferable between bacteria, thus enabling the rapid dissemi-
nation and maintenance of resistance genes between bacteria of 
different species23,24. Although antimicrobials are not recommended 
for the treatment of uncomplicated gastroenteritis, they are com-
monly administered to diarrhoeic children in developing countries 
to treat dysentery25 and prolonged diarrhoea, of which aEPEC is a 
major cause4,5.
Here we present AMR data for 185 aEPEC isolates collected dur-
ing the Global Enteric Multicenter Study (GEMS)1,26. Using pheno-
typic susceptibility data and whole-genome sequence analysis, we 
determined the prevalence, mechanisms of resistance and poten-
tial drivers of variation in AMR profiles. These isolates, collected 
from healthy children living in a community setting and children 
with diarrhoea at seven sites in sub-Saharan Africa and South Asia, 
provided a unique opportunity to investigate the prevalence of 
AMR in intestinal bacteria that were not selected on the basis of 
AMR profile.
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The dynamics of antimicrobial resistance (AMR) in developing countries are poorly understood, especially in community 
settings, due to a sparsity of data on AMR prevalence and genetics. We used a combination of phenotyping, genomics and 
antimicrobial usage data to investigate patterns of AMR amongst atypical enteropathogenic Escherichia coli (aEPEC) strains 
isolated from children younger than five years old in seven developing countries (four in sub-Saharan Africa and three in South 
Asia) over a three-year period. We detected high rates of AMR, with 65% of isolates displaying resistance to three or more 
drug classes. Whole-genome sequencing revealed a diversity of known genetic mechanisms for AMR that accounted for > 95% 
of phenotypic resistance, with comparable rates amongst aEPEC strains associated with diarrhoea or asymptomatic carriage. 
Genetic determinants of AMR were associated with the geographic location of isolates, not E. coli lineage, and AMR genes were 
frequently co-located, potentially enabling the acquisition of multi-drug resistance in a single step. Comparison of AMR with 
antimicrobial usage data showed that the prevalence of resistance to fluoroquinolones and third-generation cephalosporins 
was correlated with usage, which was higher in South Asia than in Africa. This study provides much-needed insights into the 
frequency and mechanisms of AMR in intestinal E. coli in children living in community settings in developing countries.
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Results
Antimicrobial susceptibility profiles. Susceptibility testing of 
185 aEPEC isolates (Supplementary Table 1) to 16 antimicrobi-
als (Supplementary Table 2) revealed resistance to 14 of the drugs 
investigated (Fig. 1a; Supplementary Table 3), with 121 MDR iso-
lates (65%; Fig. 1c). No resistance was detected to the ‘last-line’ 
drugs, amikacin (an aminoglycoside) or meropenem (a carbape-
nem). Only 35 isolates (19%) were susceptible to all drugs tested: 
17 from cases (18%) and 18 from controls (20%). Resistance to 
‘older’ antimicrobials was common, with 121 (65%) isolates resis-
tant to ampicillin, 124 (67%) to trimethoprim, 122 (66%) to trime-
thoprim/sulphamethoxazole and 104 (56%) to tetracycline (Fig. 1a). 
Approximately half (n = 96, 52%) the isolates were resistant to three 
or more of these drugs. Streptomycin resistance was common (43%), 
although this antibiotic is not used to treat diarrhoea. Resistance to 
other aminoglycosides tested was rare (3%), with five isolates from 
India resistant to tobramycin, four of which were also resistant to 
gentamicin. Fluoroquinolone resistance was relatively infrequent, 
with 31 isolates (17%) resistant to norfloxacin and 8 (4%) resistant 
to both norfloxacin and ciprofloxacin. Resistance to chlorampheni-
col (11%) and azithromycin (7%) was also infrequent. Among the 
β -lactam antibiotics, ampicillin resistance was common (65%), but 
resistance to ceftriaxone (3%), ceftazidime (3%) and cefepime (2%) 
was rare (Fig. 1a,b).
Genetic determinants of AMR. The genomes of the 185 aEPEC 
isolates were screened for known genetic determinants of AMR, 
including horizontally acquired genes and point mutations in chro-
mosomal genes associated with resistance to fluoroquinolones and 
nitrofurantoin (Fig. 1b; Supplementary Fig. 1 and Supplementary 
Table 4). More than forty different acquired AMR genes were 
detected, along with four point mutations (two in gyrA, one in parC 
(both gyrA and parC are associated with quinolone resistance) and 
one in nfsA (associated with resistance to nitrofurantoin)). Extensive 
diversity of AMR genotypes was observed, with 104 distinct com-
binations of AMR determinants across the 185 isolates (Fig. 1b, 
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Fig. 1 | Prevalence of AMR-associated gene content and AMR phenotypes in 185 aEPEc isolates.  a,c AMR phenotypes of the aEPEC isolates. a, AMR 
profiles grouped by the drug class to which aEPEC strains were phenotypically resistant. c, Histogram illustrating the number of drug classes to which 
aEPEC strains were phenotypically resistant. b,d AMR-associated gene content of aEPEC strains. b, Genes detected in the genomes associated with AMR 
are shown to the left of the graph and are grouped by drug class. Gene that contain point mutations that result in AMR and that are not acquired through 
horizontal gene transfer are indicated with a cross. d, Histogram illustrating the number of classes to which aEPEC strains were detected as having  
AMR-associated gene content.
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Supplementary Fig. 1). Nevertheless, four acquired AMR genes 
were detected in more than half the isolates. These were alleles of 
blaTEM (ampicillin), strA and strB (streptomycin), and sul2 (sulphon-
amides). Alleles of dihydrofolate reductase (dfr) genes encoding 
trimethoprim resistance were detected in 132 (71%) isolates. The 
most common of these were dfrA1 (12%), dfrA5 (23%), dfrA7 (20%) 
and dfrA8 (16%).
Investigation of mobile genetic elements associated with trans-
fer of AMR genes. As MDR was common in the bacteria studied 
(Fig. 1), we hypothesized that this was due to the co-transfer of 
groups of AMR genes via mobile elements. The pairwise co-occur-
rence matrix of AMR genes was sparse (Supplementary Fig. 2), with 
only a few clusters of genes frequently detected together in the same 
genome. The mean co-occurrence value across all gene pairs was 
6.4 strains. Figure 2a shows AMR gene co-occurrence networks, 
constructed using different thresholds for co-occurrence across 
the aEPEC collection. The most common gene network comprised 
sul2, strA and strB, which co-occurred in 112 genomes (61%); the 
combination of sul2, strA and strB occurred with blaTEM-198 in 46 
(25%) and with blaTEM-191 in 20 (11%; and Supplementary Fig. 2 and 
Fig. 2a) genomes. Using a minimum threshold of co-occurrence in 
≥ 20 strains (mean plus s. d. of all co-occurrence values), we detected 
a large network of genes comprising sul2, strA, strB and blaTEM-198, as 
well as sul1, blaTEM-191, dfrA14, dfrA8, dfrA7, tet(A) and tet(B).
Resolving the genetic context of AMR genes is generally not 
possible using short-read sequence data, because repeated 
sequences (such as insertion sequences) and variable plasmid copy 
numbers cause uncertainty in the de novo assembly graphs27,28. 
We therefore sought only to make broad classifications about 
the potential mobile elements associated with the AMR gene 
networks present in the aEPEC genomes, through comparison 
with elements that have previously been found to mobilize these 
combinations of genes.
The genes sul2, strA and strB frequently move together on small 
(approximately 6,000 base pairs (kbp)) plasmids related to pCERC229 
(Fig. 2b). The combination of the pCERC2 plasmid backbone and 
the sul2, strA and strB sequences was present in 42 isolates, 40 of 
which (95%) also carried dfrA gene sequences, including dfrA1, 
dfrA14 and dfrA8. In some genomes, the plasmid sequences could 
be resolved completely, showing that the dfr gene was located on the 
plasmid. For example, GEMS strain 400897 carried dfrA1 gene adja-
cent to strB on a pCERC2-like plasmid, while GEMS strain 402635 
carried dfrA14 inserted within strA as in pCERC129 (Fig. 2b).
The sul2, strA and strB genes also occur together with blaTEM genes 
(predominately blaTEM-198) in transposon Tn6029, which is com-
monly found in E. coli in a range of distinct plasmid backbones27,29,30 
(Fig. 2c). Tn6029 is mobilized by the flanking copies of IS26. A third 
copy of IS26 is located between blaTEM and the other AMR genes, 
resulting in separation of the transposon into two separate contigs 
in short-read assemblies (Fig. 2c). We detected the presence of both 
Tn6029 contigs in 33 genomes, which are therefore likely to carry 
the complete transposon. As the flanking IS26 sequence is present in 
many different locations, we could not determine the insertion site 
of Tn6029 within the draft genomes. However, Tn6029 is frequently 
located within Tn1696, which includes a class I integron that carries 
variable AMR genes (often including dfr genes) within the cassette, 
and sul1 downstream of the cassette. For an example of a compos-
ite transposon structure from Salmonella plasmid pSRC2631, see 
Fig. 2c. In total, we identified class I integron sequences in 38 aEPEC 
genomes, 26 of which included both Tn6029 contigs. An example 
assembly graph, showing how these contigs are connected to one 
another in a manner consistent with previously sequenced compo-
site transposons, is shown in Fig. 2c. Overall, we identified five 
different integron gene cassettes, the most prevalent of which car-
ried dfrA7 (n = 30 genomes, including 25 with Tn6029), whereas the 
others carried dfrA1 (n = 4), dfrA1 and aadA (n = 1 genome, which 
also carried Tn6029), dfrA17 and aad5 (n = 2), and dfrA5 (n = 1).
We found two common genes that encode tetracycline resistance 
efflux pumps. The most prevalent was tet(A), which was found in 
63 (34%) aEPEC genomes. Although tet(A) is associated with the 
Tn1721 transposon, the full transposon was detected in only three 
genomes. The tet(B) gene was detected in 50 (27%) genomes, five 
of which also carried tet(A). The tet(B) gene can be mobilized by 
Tn10, which is flanked by IS10 genes, but the complete transposon 
was present in only two genomes. The linkage of tet(A) or tet(B) 
to other AMR-related elements was not resolvable from the draft 
genome assemblies, however both were found in association with 
other common AMR genes (Fig. 2a).
Although it is not possible to resolve plasmid sequences from 
draft short-read assemblies or determine linkage between specific 
plasmid replicons and AMR genes32, our screening for markers of 
plasmid replicons revealed several that are often associated with 
large AMR plasmids (Supplementary Fig. 1d). The most prevalent 
amongst the aEPEC collection were FII (n = 131, 71%) and FIBA 
(n = 104, 56%). Notably, F plasmids are also associated with the 
carriage of genes for virulence determinants, such as adhesins of 
enteropathogenic E. coli, but our data did not permit the determi-
nation of which plasmids were associated with AMR genes versus 
virulence genes. An IncC plasmid replicon (also known as IncA/C) 
was detected in four genomes that carried blaTEM-198 but not sul2, 
strA or strB. It was not possible, however, to determine whether the 
blaTEM-198 gene was located on this plasmid.
Prediction of AMR phenotypes from genotypes. In vitro resis-
tance was largely explained by the presence of known genetic deter-
minants of AMR (Fig. 1, Table 1). For most drugs, the detection 
of resistance genes was both sensitive (> 95%) and specific (> 90%) 
in predicting AMR phenotype. The frequency of very major errors 
(failure to detect phenotypic resistance) exceeded the minimum 
acceptable threshold of 1.5% for five drugs (Table 1). These were: 
ampicillin (4.9%), streptomycin (2.2%), trimethoprim (2.2%), tri-
methoprim/sulphamethoxazole (2.2%) and tetracycline (2.2%). 
Major errors (predicting resistance when none is present) were 
also detected for these and several other antimicrobials (Table 1). 
The highest major error rates were observed for streptomycin 
(26.5%), ampicillin (7.0%), trimethoprim (5.9%), trimethoprim/
sulphamethoxazole (5.4%) and tetracycline (4.3%). The sensitivity, 
specificity, positive predictive value (PPV) and negative predictive 
value (NPV) for each drug are shown in Supplementary Table 5. 
Sensitivity and NPV were greater than 90% for all drugs tested 
with the exception of azithromycin (85% sensitivity) and ampicillin 
(85% NPV). Specificity and PPV were more variable, reflecting the 
error rates summarized above (Table 1).
Potential sources of variation in AMR profiles. Given the diversity 
of AMR profiles in our aEPEC strains, we determined whether the 
distribution of AMR genes was associated with disease status, phy-
logenetic lineage or the geographic location from which each strain 
was isolated. First, we compared the frequency of AMR phenotypes 
and genotypes among aEPEC isolated from diarrhoea cases and 
asymptomatic controls. Only data from confirmed cases (n = 94) 
and controls (n = 88) were used for this analysis. For each drug class, 
neither AMR phenotype nor AMR predicted from genotype, were 
statistically different between cases and controls (Supplementary 
Table 6). The frequencies of individual AMR genes were also similar 
in isolates obtained from cases and from controls (Fig. 3a). As AMR 
determinants were equally distributed among cases and controls, all 
isolates were pooled for further analysis of lineage and region.
Discriminant analysis of principal components33 on the binary 
matrix of AMR genetic determinants (Supplementary Table 4; 
Fig. 3b,c) revealed that the first 20 principal components accounted 
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for > 93% of variation in AMR profiles and were retained for 
discriminant analysis by phylogenetic lineage (clonal groups as 
defined previously6; Supplementary Fig. 1) or by geographic origin 
(East Africa, West Africa and Asia; Fig. 3 and Supplementary Fig. 3).
Variation in AMR was not associated with clonal group, apart 
from CG378 which was characterized by the absence of the most 
common AMR genes: blaTEM variants, sul2, tet(A) and tet(B), and 
the presence of the uncommon catA gene, detected in 7 of 9 CG378 
isolates compared to 15 of 176 non-CG378 (P < 10-4, Fisher’s exact 
test, two-tailed). Variation in AMR determinants was associated 
with the region of origin (Fig. 3b and Supplementary Fig. 3b). 
Discriminant function 1 (DF1) separated Asian from African 
isolates and was associated with gyrA single nucleotide polymor-
phisms; DF2 separated East from West African isolates and was 
associated with dfrA8, dfrA5, tet(A) and sul2. Figure 3d shows the 
distribution of the dfrA alleles across the GEMS sites. For example, 
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dfrA1 predominated at Asian sites and dfrA8 was most common 
at West African sites, whereas dfrA14 and dhfr7 were common in 
Mozambique and Kenya, respectively. Further, tet(A) was more 
common at West and East African sites than in Asia. These genetic 
differences were reflected in AMR phenotypes, as resistance to 
ciprofloxacin (n = 8, 12%) and third-generation cephalosporins 
(ceftazidime and ceftriaxone, both n = 6; 9%) was identified only 
in strains from Asia, while resistance to tetracycline was more com-
mon in African (East Africa, n = 44, 60%; West Africa, n = 33, 72%) 
than in Asian isolates, n = 27, 41 %; P < 0.05, Fisher’s exact test, 
two-tailed; Fig. 4a).
Differences in local antimicrobial drug usage. The broad pat-
terns of antimicrobial use in the treatment of diarrhoea across the 
GEMS study sites showed that trimethoprim/sulphamethoxazole 
and penicillins were used more frequently at African sites, whereas 
macrolides (azithromycin) and fluoroquinolones (in particular cip-
rofloxacin) were used more frequently in Asia (Fig. 4b,c). These 
patterns of antimicrobial use showed some association with AMR 
phenotypes, insofar as we observed higher levels of both usage and 
resistance for azithromycin and fluoroquinolones at Asian sites, and 
to trimethoprim at East African sites (Fig. 4). We could not for-
mally test these associations, however, due to the small numbers of 
observations at some study sites and minor variations in usage of 
most drugs between the sites. We therefore investigated the associa-
tions between usage and resistance for the two drugs that showed 
substantial usage (> 10%) at three or more study sites: ciprofloxacin 
and trimethoprim. Across the seven sites, ciprofloxacin usage was 
significantly associated with the prevalence of substitutions in the 
quinolone resistance-determining regions (QRDRs), gyrA and parC 
(Coefficient of determination (R2) = 0.87, P = 0.002; Fig. 5). By con-
trast, trimethoprim usage was not associated with the prevalence of 
horizontally acquired dfr genes that confer resistance to the drug 
(R2 = 0.04, P > 0.5).
Discussion
AMR and usage data reported here were collected at seven study 
sites in Asia and Africa, using the same protocols thus enabling 
comparisons between the sites26,34. No national AMR surveillance 
data are available from these countries; and AMR data on E. coli 
in these countries pertain mostly to isolates causing extra-intestinal 
infections, and to a limited number of drugs (mainly third-gener-
ation cephalosporins and fluoroquinolones)14,19,21,22,35. Furthermore, 
publicly available background data on antimicrobial usage at the 
seven study sites are limited. For example, the IMS Health MIDAS 
database includes usage data for India, Pakistan and Bangladesh 
reported in aggregate without detailed methods of data collec-
tion or interpretation; and no data for Mozambique, The Gambia, 
Kenya and Mali.
Nearly half of all isolates were resistant to penicillins, trim-
ethoprim and tetracyclines. The rates of resistance to these drugs 
were generally lower amongst Asian isolates (21–62%) than in 
Table 1 | comparison of phenotypic and genotypic AMR profiles of 185 aEPEc isolates
Resistant 
phenotype
Resistant 
genotype
Very major 
errora
Susceptible 
phenotype
Susceptible 
genotype
Major errorb
β-lactams
Ampicillin 121 112 9 (4.9%) 64 51 13 (7.0%)
Cefepime 3 3 0 182 178 4 (2.2%)
Ceftriaxone 6 6 0 179 174 5 (2.7%)
Ceftazidime 6 6 0 179 174 5 (2.7%)
Meropenem 0 0 0 185 185 0
Aminoglycosides
Streptomycin 80 76 4 (2.2%) 105 56 49 (26.5%)
Gentamicin 5 5 0 180 180 0
Tobramycin 5 5 0 180 180 0
Amikacin 0 0 0 185 185 0
Folate pathway inhibitors
Trimethoprim 124 120 4 (2.2%) 61 50 11 (5.9%)
Trimethoprim/sulphamethoxazolec 122 118 4 (2.2%) 63 53 10 (5.4%)
Nitrofurantoin
Nitrofurantoin 0 0 0 185 182 3 (1.6%)
chloramphenicol
Chloramphenicol 21 19 2 (1.1%) 164 160 4 (2.2%)
Macrolides
Azithromycin 13 11 2 (1.1%) 172 166 6 (3.2%)
tetracyclines
Tetracycline 104 100 4 (2.2%) 81 73 8 (4.3%)
Fluoroquinolones
Ciprofloxacind 8 8 0 177 173 4 (2.2%)
Norfloxacin 31 30 1 (0.5%) 154 149 5 (2.7%)
aVery major errors (resistant isolate genotyped as susceptible) at frequencies > 1.5% are shown in bold. bMajor errors (susceptible isolate genotyped as resistant) at frequencies > 3% are shown in bold. 
cWhen two genes are required for resistance, both were required for genotypic resistance: strA and strB for streptomycin, and a dfr gene plus a sul gene for resistance to trimethoprim/sulphamethoxazole. 
dAt least one point mutation in gyrA and a second in gyrA, gyrB, parC or parE.
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Africa isolates (59–84%); whereas resistance to newer drugs such 
as ceftriaxone, fluoroquinolones and azithromycin were detected at 
the Asian sites (Fig. 4a). These patterns were broadly consistent with 
the antimicrobial usage data at the corresponding study sites, which 
showed that ciprofloxacin and azithromycin were commonly used 
to treat diarrhoea in Asia, whereas trimethoprim-sulphamethoxa-
zole was the mainstay of treatment in Africa (Fig. 4b,c). The high 
frequencies of ciprofloxacin resistance at the Asian sites are simi-
lar to rates previously reported among clinical cases of intestinal 
E. coli (including multiple pathotypes) in these countries17,19,21,22,36. 
We detected ESBL-producing isolates at the Asian, but not the 
African, study sites. Much higher levels have been reported from 
extra-intestinal E. coli infections (including bacteraemia) in 
hospitals in Asia and Africa16,19,35, we speculate that this may 
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reflect selection due to use of third-generation cephalosporin 
at higher rates in hospitals than in the community, and/or the dis-
semination of the ESBL-producing extra-intestinal E. coli lineages, 
such as ST131.
In agreement with our data relating to AMR phenotypes, we 
found that the genetic determinants of resistance were similar in 
bacteria isolated from diarrhoeal cases and asymptomatic controls 
(Fig. 3a, Supplementary Table 6) and were not associated with the 
clonal lineage of the strain, but associated with the geographic region 
where the bacteria were isolated (Fig. 3b,c; Supplementary Fig. 3). 
These findings are consistent with the hypothesis that differences in 
the frequencies of AMR-encoding genes in different regions reflect 
selection due to differences in antimicrobial exposure (Fig. 4b,c). 
In strong support of this explanation, mutations in the QRDRs 
of gyrA and parC were significantly associated with the frequency 
of ciprofloxacin use across the seven study sites (Fig. 5). The same 
pattern of point mutations in the QRDRs of chromosomal genes 
has been observed in other Enterobacteriaceae associated with 
South Asia, including Salmonella enterica serovar Typhi37,38 and 
Shigella sonnei39.
The situation was more complex for horizontally transferred AMR 
genes associated with resistance to older drugs. Although individual 
dfr alleles were distributed differently across sites (Fig. 3d) 
and contributed to orthogonal components of the regional dis-
criminant function (Fig. 3b), the overall prevalence of dfr genes was 
relatively high (50–90%) at each site and not significantly associ-
ated with use of trimethoprim for diarrhoea (Figs. 3d and 4b,c). 
Similarly, genes encoding resistance to ampicillin, streptomycin 
and tetracycline were common at sites where these drugs were sel-
dom or never used for the treatment of diarrhoea. We also found 
evidence of several common elements mediating AMR to these 
older drugs, including small plasmids and class I integrons (Fig. 2). 
This could be due to: (1) a lack of fitness cost associated with these 
resistances, resulting in maintenance of the genes in the E. coli 
population after drug usage declines8,10,30,40,41; (2) co-selection for 
resistance to multiple drugs whose associated genes are present 
on the same mobile elements42,43; and/or (3) selection due to drug 
exposure unrelated to the treatment of diarrhoea. We could not 
distinguish between hypotheses using our data, although exposure 
to anti microbials from other sources is quite likely. For example, 
although we found that trimethoprim, alone or combined with sul-
phamethoxazole, was used less frequently in India than alternative 
agents for the treatment of diarrhoea, other studies have reported 
frequent use of trimethoprim in hospitals, community settings36 
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and agriculture in India; there is also evidence of its presence in 
the environment, particularly surface waters44. Future studies would 
benefit from additional data on clinical and agricultural antimicro-
bial exposures, and assays for selected antimicrobials agents in urine 
and the environment.
We were also unable to determine the precise location of most 
AMR genes and associated mobile elements from our short-read 
sequence data. Further experiments such as conjugation or long-
read sequencing38,45,46 could resolve this in future. It is notable, how-
ever, that the pCERC-like plasmids (which often carried resistance 
to streptomycin, sulphonamides and trimethoprim) are common 
in E. coli, possibly because their small size (~6 kb) imposes a low 
fitness cost29,47. It is also notable that these and many of the other 
AMR genes we detected are also associated with composite transpo-
sons that can integrate into the bacterial chromosome, where they 
are maintained at lower fitness cost than large resistance-encoding 
plasmids27,31,38. Many of the mobile elements we detected have been 
reported widely in E. coli and other Enterobacteriaceae from human 
intestinal and extra-intestinal samples and animal samples29,38,48–50. 
Atypical enteropathogenic E. coli has multiple reservoirs and our 
collection included extensive phylogenetic diversity within the 
E. coli population (90 unique lineages6); and we found no differ-
ences in AMR between isolates cultured from cases and asymp-
tomatic colonization. Thus, although the isolates were not collected 
for the specific purpose of AMR surveillance, they may be broadly 
representative of intestinal E. coli in these settings.
Our data fill important information gaps concerning the preva-
lence of AMR among intestinal E. coli in children from develop-
ing countries in Africa and Asia. In particular, our study showed 
that resistance to multiple ‘older’ drugs (ampicillin, tetracycline, 
streptomycin and trimethoprim-sulphamethoxazole) was com-
mon at all sites, and that resistance to ‘newer’ antimicrobials, such 
as fluoroquinolones and azithromycin, has emerged only in Asian 
sites where these drugs are used in the management of diarrhoea. 
Resistance to older drugs was also common at these sites, such that 
only Asian isolates were resistant to seven or eight categories of 
antimicrobials, indicating that changing patterns of antimicrobial 
use leads to an accumulation of resistance determinants rather than 
their replacement.
Methods
aEPEC isolates and corresponding whole-genome sequences. A total of 185 
confirmed aEPEC isolates from children aged 0–5 years at GEMS sites located in 
The Gambia, Mali, Kenya, Mozambique, Bangladesh, India and Pakistan34 were 
included in the analysis1,6,26,34. Their collection, selection for sequencing, whole-
genome sequencing and phylogenomic analysis have been described previously6. 
Briefly, the isolates were mostly from fecal samples in which aEPEC alone (or with 
Giardia lamblia) was the only pathogen detected, where a pure culture could be 
obtained. All such isolates from diarrhoeal cases were sequenced (n = 94); controls 
matched for age, sex and study site were also included (n = 88). Three isolates 
were from children whose case/control status was uncertain. Faecal samples were 
collected at the study sites before antimicrobial treatment, although previous 
exposure to antimicrobials from other sources cannot be ruled out. Control 
children were also not receiving any antimicrobial treatment.
Whole-genome sequences were generated for all 185 aEPEC isolates at the 
Wellcome Trust Sanger Institute using the Illumina HiSeq platform (100 bp paired-
end reads) and assembled using Velvet, as described previously6,51. Details of the 
individual isolates, accession numbers for the corresponding genome sequence 
reads and assemblies (deposited collectively under BioProject ERP001141), and 
associated metadata are provided in Supplementary Table 1.
Phenotypic characterization of AMR profiles. Antimicrobial susceptibility 
testing to 16 antimicrobials was performed using the VITEK2 (bioMérieux) 
system or an agar-dilution method. A summary of the drugs, testing methods, 
and the minimum inhibitory concentration (MIC) breakpoints used to 
determine susceptible, intermediate or resistant status for each drug is shown in 
Supplementary Table 2. The controls used were three reference S. enterica isolates 
with known resistance profiles that were kindly provided by the Microbiological 
Diagnostic Unit Public Health Laboratory. These strains had the following 
profiles: (1) susceptible to all drugs tested; (2) resistant to ampicillin, streptomycin, 
tetracycline, chloramphenicol, sulphathiazole, trimethoprim, kanamycin, 
spectinomycin and gentamicin; and (3) resistant to streptomycinmod, tetracycline, 
kanamycin, nalidixic acid and ciprofloxacin.
For VITEK2 assays, pure isolates were streaked on MacConkey agar plates 
and incubated at 37 °C overnight. Isolates were then subcultured onto horse blood 
agar (HBA) plates for fresh culture and incubated overnight at 37 °C. One to 
three colonies were selected from each HBA plate and suspended in saline to an 
absorbancy of ~0.5 MacFarlane Units before being subjected to VITEK2 analysis. 
The raw MIC data from the VITEK2 assays are shown in Supplementary Table 7.
Susceptibility to streptomycin, chloramphenicol, azithromycin and tetracycline 
were determined using an agar-dilution method. Bacterial suspensions were 
prepared as described above. To each of 32 stainless steel wells, 450 µ l nutrient 
broth containing 0.05% agar was added, followed by 50 µ l bacterial suspension. 
Each Mueller Hinton agar antimicrobial-containing plate for susceptibility testing 
and two control Mueller Hinton and MacConkey agar plates were inoculated using 
a 32-pin replicator. Each pin delivered 2 µ l to the plate such that the final number 
of colony-forming units in each sample was ~104. Plates were incubated overnight 
at 37 °C and inspected the next day. Growth on an antimicrobial-containing 
Mueller Hinton plate was recorded as phenotypically resistant to the drug, whereas 
no growth was recorded as susceptible.
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
MIC breakpoints (version 6) were used where available52. Differences exist between 
the EUCAST and Clinical and Laboratory Standards Institute (CLSI) guidelines 
in terms of MIC breakpoints and the drugs to be tested. As tetracycline does not 
have defined MIC breakpoints under the EUCAST scheme, we used the CLSI 
MIC breakpoint. Streptomycin and azithromycin do not have established MIC 
breakpoints under either scheme53,54. Previous research proposed a breakpoint 
of 16 µ g ml-1 for streptomycin in E. coli54. Little information is available on the 
MIC distribution of azithromycin for E. coli. A breakpoint of 16 µ g ml-1 has been 
proposed for S. enterica based on a study in which the majority of isolates displayed 
MICs of 4–8 µ g ml-1(ref. 53). For the present study, the breakpoint MIC for each 
of these drugs was set at the conservative value of 16 µ g ml-1. The antimicrobial 
susceptibility data for each isolate are shown in Supplementary Table 3.
Detection of AMR genes. An SRST2-formatted version of the ARG-ANNOT 
AMR gene database55 was downloaded from https://github.com/katholt/srst2.  
All sequence read sets were screened against the database using SRST2 to detect 
the presence of known acquired resistance genes in each genome56. The  
β -lactamase genes, ampC1, ampC2 and ampH, were excluded from analysis, as in 
E. coli they are core genes that normally do not confer antibiotic resistance. The 
results were transformed into a binary table in R to indicate presence/absence of 
acquired resistance gene alleles (Supplementary Table 4).
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Detection of single nucleotide polymorphisms conferring resistance to 
fluoroquinolones and nitrofurantoin. Chromosomal mutations, known to be 
associated with resistance to fluoroquinolones in E. coli, were extracted from the 
genome-wide single nucleotide polymorphism calls obtained previously based on 
mapping the reads to the E. coli strain 12009 O103:H2 reference genome6. These 
included specific mutations in the quinolone resistance-determining regions of 
gyrA, gyrB, parC and parE57, and non-synonymous substitutions in nfsA (residues 
11–15) that confer resistance to nitrofurantoin58,59.
Statistical analysis of AMR phenotype prediction from genotype. All statistical 
analyses were performed using the R Stats Package version 3.4.0. The ability of 
genotypes to predict drug susceptibility phenotypes was assessed by comparing 
antimicrobial susceptibility phenotypes (S, I and R) with the presence of known 
AMR-associated genes and mutations. Errors in predicting antimicrobial 
susceptibility were characterized as very major (calling a resistant isolate 
susceptible) or major (calling a susceptible isolate resistant)60,61. The currently 
accepted standards for very major error and major error rates are < 1.5% and < 3%, 
respectively60. Here, very major errors were said to have occurred when an isolate 
was phenotypically resistant, but no known resistance genes or mutations were 
detected, while major errors were made when an isolate carried known resistance 
determinant(s) but was phenotypically susceptible. Statistical analysis to determine 
sensitivity, specificity, PPV and NPV were calculated in the epiR package  
(v0.9-93)62 for R, using the epi.stats function with 0.95 confidence intervals for each 
antimicrobial tested.
Genomic reconstruction of demographic groups by discriminant analysis of 
principal components. The matrix of AMR genetic determinants (specifically 
the data in Supplementary Table 4 with only AMR genetic determinants used 
and isolates with two point mutations in gyrA treated as present to generate 
a binary matrix) was used as the input for discriminant analysis of principal 
components that was implemented in the adegenet package (v2.1.0) in R33. The 
first 20 principal components, which together explained > 93% of the variance in 
AMR gene content, were retained for discriminant analysis to explore the ability 
of principal components to discriminate between groups of strains defined by 
geographic region of origin (West Africa: The Gambia and Mali; East Africa: Kenya 
and Mozambique; and Asia: Bangladesh, India and Pakistan) or clonal group 
membership. The two principal components contributing the most to discriminant 
analysis were plotted and labelled with the genetic determinants whose variation 
contributed the most to those components. The posterior group membership 
probabilities for each discriminant function were also plotted.
Construction of co-occurrence network. A pairwise co-occurrence matrix of 
acquired AMR genes was constructed by transforming the binary AMR gene 
content matrix in R. The co-occurrence relationships were visualised between all 
pairs of genes using the pheatmap package (v1.0.8) in R (https://CRAN.R-project.
org/package= pheatmap) (Supplementary Fig. 2). Networks of co-occurring genes, 
in which nodes represent genes and edges represent a frequency of co-occurrence 
exceeding a given threshold (set to ≥ 20, ≥ 33, ≥ 46, ≥ 100 genomes), were visualized 
in R using the igraph package (v1.1.2)63 in R.
Plasmid replicon screening. An SRST2-formatted version of the PlasmidFinder 
database64 was downloaded from https://github.com/katholt/srst2 for the detection 
of 80 known plasmid replicon marker sequences. All sequence read sets were 
screened against the database using SRST2 to detect the presence of these replicons 
in each genome. The results were transformed into a binary table in R to indicate 
presence/absence.
Visualization of AMR and plasmid genotypes against a core gene tree. A subtree 
representing the relationships between the 185 GEMS aEPEC isolates was extracted 
from the full core phylogeny we published previously6 by pruning all other tips 
using R packages ape (v5.1)65 and geiger (v2.0.6)66. The presence of acquired AMR 
genes, mutations and plasmid replicons was plotted as a heatmap against the 
phylogeny using the plotTree function for R (https://github.com/katholt/plotTree).
Investigation of mechanisms of AMR gene mobilisation. Common AMR-
associated genes that were shown to co-occur, specifically blaTEM-198, sul1, sul2, strA, 
strB, multiple dfrA alleles, tet(A) and tet(B), were further investigated in the aEPEC 
genome assemblies to determine whether they were carried on the same mobile 
elements. The aEPEC genome assemblies generated previously6 were interrogated 
with BLAST (v2.3.30), using as queries the AMR genes and the sequences of the 
plasmids pCERC1 (accession JN012467) and pCERC2 (accession KX291024), and 
the transposons Tn6029 (accession GQ150541)27, Tn1721 (accession X61367)67 
and Tn10 (accession AF223162)68. For example, if the pCERC2 backbone and 
AMR genes were all detected on a single contig in the genome assembly, we 
inferred that these genes were moving together on a pCERC2-related plasmid. 
Two representative aEPEC isolates that were identified as harbouring a pCERC2-
like plasmid backbone with different dfr gene insertions (strains 402635 and 
400879) were selected as representatives for further analysis. These genomes were 
re-assembled with Unicycler (v0.2.0)69, annotated using Prokka (v1.12)70 and 
compared to the reference sequences for pCERC1 and pCERC2 using BLAST.  
The comparisons were then explored using Artemis Comparison Tool71 and plotted 
with genoplotR (v0.8.7) in R72.
Atypical enteropathogenic E. coli isolates were inferred to be likely carriers of 
Tn6029 or related transposons if the entire region of repC to strB was detected by 
BLAST in a single contig and a blaTEM variant (predominately blaTEM-198) was also 
detected in the genome. (Note that it is not possible for the complete transposon 
sequence to be assembled from short reads, as blaTEM is separated from the rest 
of the transposon by repeat copies of IS26 which cause a break in the assembly 
graph). A representative strain matching this pattern (401596) was re-assembled 
with Unicycler69 and the connectivity of Tn6029 genes in the resulting assembly 
graphs were visualised using Bandage (v0.8.1)73.
The distributions of class I integrons with different cassette regions were 
explored by extracting the DNA sequences spanning from int1 to sul1 genes using 
BLAST and MUMmer (v3.23)74. Different dfrA alleles were identified within 
the resulting sequences via BLAST searches of the ARG-ANNOT database55. 
Representatives of each distinct class I integron sequence (defined by the dfrA gene 
carried) were re-assembled with Unicycler69 and submitted to the Repository of 
Antibiotic-resistance Cassettes (RAC) website75 for detailed annotation.
Antimicrobial usage data and correlation with resistance. Data on the use of 
antimicrobials at each of the seven GEMS sites were collected as part of the original 
GEMS protocol1,26. These data included details of the antimicrobials prescribed 
to all cases presenting with watery diarrhoea or dysentery at the study clinics and 
were documented by a member of the GEMS clinical team26. Two of the recorded 
drugs were excluded from the current analysis: pivmecillinam, because it was not 
used at any discernible level, and metronidazole, which is active against obligate 
anaerobic protozoa and bacteria only76 and therefore does not pertain to E. coli, 
which is intrinsically resistant to this agent. The frequency of prescriptions for each 
drug at each site was visualized in R, using the ggplot2 package (v2.2.1)33.
The relationship between frequencies of ciprofloxacin and trimethoprim 
usage and associated genetic determinants was investigated via linear regression 
modelling in R using the lm function. For ciprofloxacin, the genetic determinants 
were either one or more quinolone resistance-associated point mutations in gyrA 
(point mutations in parC only occurred when gyrA mutations were also present), 
or the presence of the plasmid-borne genes qepA or qnrS. Genetic evidence of 
trimethoprim/sulphamethoxazole resistance required the combination of at least 
one dfrA gene together with sul1 or sul2. The data were visualized in R using the 
ggplot2 package33.
Data availability. Accession numbers for the short-read data and associated 
metadata are listed in Supplementary Table 1. The phenotypic resistance data are 
provided in Supplementary Tables 3 and 7 and the genotypic resistance profiles are 
shown in Supplementary Table 4.
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